Target intelligence / Profile preview

Melanin biosynthesis enzyme

Molecular classification
Enzyme
01

Overview

Melanin biosynthesis enzymes" refers to a group of enzymes, primarily **tyrosinase**, **tyrosinase-related protein-1 (TYRP1)**, and **tyrosinase-related protein-2 (TYRP2/DCT)**, which catalyze key steps in the generation of melanin pigments from tyrosine in melanocytes[1][3][5]. Tyrosinase is the principal, rate-limiting enzyme responsible for hydroxylating tyrosine to L-DOPA and further oxidizing L-DOPA to dopaquinone, from which melanin subtypes (eumelanin and pheomelanin) are synthesized[1][3][5]. TYRP1 and TYRP2 participate in downstream reactions, influencing the type and amount of melanin produced[3]. Dysregulation, mutation, or abnormal expression of these enzymes is implicated in pigmentary disorders and melanoma[3]. Many skin lightening or depigmenting agents are targeted toward inhibiting these enzymes directly or indirectly[4][6].\n**Note:** "Melanin biosynthesis enzymes" is not a canonical molecular target but an umbrella term for a family of enzymes, mainly tyrosinase (the key and best-defined target), along with TYRP1 and TYRP2. Proper targets are the specific enzymes, most notably tyrosinase. Thus, this entry is flagged as *is_incorrect: true* due to lack of specificity[3].

Other names
TyrosinaseTyrosinase-related protein-1 (TYRP1)Tyrosinase-related protein-2 (TYRP2)Dopachrome tautomerase (DCT)Melanogenesis enzyme
02

Mechanism of action

Tyrosinase inhibition; MITF modulation; Copper-chelation; ERK pathway activation; RNA interference; cAMP pathway inhibition

03

Biological functions

Melanin biosynthesisPigmentationProtection against UV radiationRegulation of skin, hair, and eye color
04

Disease associations

Skin disorders (albinism, vitiligo)MelanomaHyperpigmentationHypopigmentationOther pigment disorders
05

Safety considerations

Potential cytotoxicity (e.g., hydroquinone mutagenicity, arbutin hydrolysis toxicity)Skin irritationCarcinogenicity (kojic acid)Adverse reactions with long-term or excessive use
06

Interacting drugs

Hydroquinone

10 more in the full profile.

07

Biomarkers

Expression of tyrosinase and related enzymes (TYR, TYRP1, TYRP2)Melanin contentMITF levels

Beyond the preview

Go deeper on Melanin biosynthesis enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanin biosynthesis enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call